background preloader

Ddiclinical

Facebook Twitter

ddiclinical

Makrocare. Regulatory requirements change daily.

makrocare

While some countries provide these well on their websites, most countries getting updated or accurate information is a challenge. For your product strategy, in addition to just country regulations, sometimes you may need “big picture” that covers clinical, competitor products, labels, latest regulatory news, safety issues and more How should a Biopharma company prepare for upcoming changes, and how do you ensure timely review of guidelines?

How can the impact of the changes be assessed? eIFU Electronic Labeling. Clinical trial randomization tool. Biopharma Labeling Wish list 2021. Biopharma Labeling Wish list 2021 December 17, 2020 Labeling Automation 1.

Biopharma Labeling Wish list 2021

Solutions to Inaccurate Labeling Automation Tools: Many tools have failed to keep labeling processes up to date by maintaining regulatory standards. Some automated drug labeling tools provide on-demand label creations, annotations, label classifications, conversions, and data extractions by using a set of business rules to turn unstructured label data into structured label data and build corresponding regulatory standards. 2. Every labeling document needs to be quality checked before its submission so that it can face the challenges of critical labeling compliance during the post-marketing surveillance stage.

Measures to Overcome Low Stock Supplies in Clinical Trials Using IRT. Measures to Overcome Low Stock Supplies in Clinical Trials Using IRT September 28, 2020 Clinical Trial Supplies Management Management of clinical supplies in clinical trials has become a major hurdle in this new era of clinical research.

Measures to Overcome Low Stock Supplies in Clinical Trials Using IRT

With the complex challenges that clinical trials shoot in terms of the design or the study population or the subgroup categorization has put the supply chain managers in a critical pose. IRT shall ease the work of the Supply Chain Managers by taking prior measures of a few main factors that hamper the management of the clinical supplies at sites. A few of the main factors to be considered to take appropriate measures are: Maintaining an adequate quantity of supplies at site by the time the site is activated and the enrollment process is initiated.

IRT measures to overcome the Low Stock Supplies at Sites: Randomization and trail management system. Labeling Automation Platform for Drugs & Devices. LABELai is a patent-pending tool that enables companies achieves their End-to-End regulatory labeling goals.

Labeling Automation Platform for Drugs & Devices

With option of using the system for either Label Lifecycle Management (LLM) or Label Operations or both, companies can pick the part of the tool that enhances their productivity and efficiency. Content part ensures top-down approach linking content and operations seamlessly. LABELai utilizes Artificial Intelligence and NLP business rules internally coupled with local country requirements (Reg Intel built-in) and all of this delivered in a cloud platform to reduce IT burden drastically.

In turn, all label aspects managed automatically without manual efforts. With the use of an automated tool, labeling teams can reduce time, costs and non compliance challenges. End to End (E2E) Label Operations. Clinical Supplies forecasting and Planning. Regulatory Automation. Automation has its impact on all industries and business functions today and making it’s mark aggressively every year.

Regulatory Automation

It’s making major impact in some areas with advanced methods (like AI and Machine Learning) while other areas are limited to simpler process automation with simpler methods (like RPA, BPM, Digitization). DDi’s REGai™ is currently the TOP platform for automating several processes in Reg Affairs, Reg Ops, Regulatory Writing and CMC functions. Uniqueness to the platform is brought in by domain specific Ontologies built-in which helps companies leverage the knowledge in tool Day 1. From technology point of view, depending on the business function, it uses a combination of NLP (for reading from legacy pdf/word documents), NLG(for humanizing the text writing automatically) and BPM for workflows.

Our Reg Intel database is integrated to provide real-time inputs into the strategy and change impact assessment. 20-70% efficiency gains. Regulatory Information Management Software. Clinical, Regulatory & Automation solutions for Life Sciences. Randomisation and Trial Supply Management. Clinical Supplies forecasting and management tool. Clinical Trial Supplies Management Solution. Factors that Unify IRT in Clinical Supplies. Main Factors that Unify IRT in Clinical Supplies September 24, 2020 Clinical Trial Supplies Management IRT has created its footprint in the field of clinical research and has evolved drastically in such a way that it has bought a major difference in perspective of clinical trials over the decades.

Factors that Unify IRT in Clinical Supplies

It faceted itself into the streams from only randomizing the subject and assigning them to a treatment group to managing the overall supplies required throughout the study through supply management. Multiple factors fall in line to manage the supplies throughout the study, where few of them are the number of subjects expected to be enrolled in each site, the number of days the shipments reached the site physically, etc.

Initial ordering of Supplies: This is one of the main facets that enable the function of supply management. Labeling Automation Platform for Drugs & Devices. Clinical Trial Supplies Management Solution. Label Tracking: An Important Aspect In Production Distribution. Label Tracking: An Important Aspect In Production Distribution July 30, 2020 Drug labelling has changed over time because of evolving regulations and has increased in content and length, with a standard format to guide the safe and effective use of the drug.

Label Tracking: An Important Aspect In Production Distribution

Product labels (drug or devices) contain comprehensive information enriched with product details, such as disease indications, target populations, drug-drug interactions, and ADRs. The labels and labelling documents prepared by manufacturers and approved by the Health Authorities, in its final form, reflect the collective input from regulators, drug manufacturers, and scientific experts. Drug-labelling data is an important resource for diverse applications, including support for policy development.

The global labelling management process continues to be a burden on the life sciences industry and is multiplying at a pace that is already becoming increasingly difficult to manage. Ddismart. Blog Clinical Trials througFDA/EU/MHRA/TGA Clin monitoring suggestions COVIDh Direct To Patient in COVID 19. AI-driven Clinical Automation & Analytics Platform.

DDI Clinical